BioSpace News Archive

Centene Corporation and the Pro Football Hall of Fame recently launched a PSA campaign to educate people across the U.S. about the safety and importance of the COVID-19 vaccine, with a particular focus on communities of color.

GlobalMed, an international provider of virtual health solutions, is proud to introduce the market release of its TotalExam® Lite camera, available in both general exam and otoscope variants.

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced that Dr. David R. Parkinson, Chief Executive Officer of ESSA Pharma, will be presenting at the upcoming Bloom Burton & Co. Healthcare Investor Conference, taking place virtually April 20-21, 2021.

BioAge Labs, Inc. a biotechnology company developing medications that target the molecular causes of aging to extend healthy human life, announced that it has entered into an exclusive worldwide license agreement with Amgen, Inc.

StrideBio receives exclusive license to novel cross-species evolved AAV vectors and an enzymatic approach for neutralizing antibody evasion

Antibe Therapeutics Inc., a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for inflammation arising from a wide range of medical conditions, is pleased to announce its participation in the Bloom Burton & Co. Healthcare Investor Conference being held virtually on Tuesday, April 20 and Wednesday, April 21.

TSHA-113 significantly reduced tau mRNA and protein levels in mouse models of human tauopathies via cerebral spinal fluid (CSF) delivery supporting further preclinical development

Lexaria Bioscience Corp. announced that its corporate client Amari Corp.'s “Everyday Calm” CBD product was named a Top CBD Product Pick by New Hope Network

Inozyme Pharma, Inc. , a rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization disorders, today presented data that highlight the burden of disease for patients and families affected by ENPP1 Deficiency and ABCC6 Deficiency, two devastating and potentially deadly genetic diseases. In a poster entitled,

Ms. Maldonado to Oversee Manufacturing Development of Codagenix’s Vaccines as Clinical Trials for COVID-19, RSV and Flu Progress